Ophthalmic Spin-Offs Alcon, AMO See Stock Gains In 2002, Join MDDI Index
This article was originally published in The Gray Sheet
Executive Summary
Ophthalmic device makers Alcon and Advanced Medical Optics (AMO) were both able to achieve double-digit stock price percentage gains in 2002 after debuting as independent firms, in part due to expanding sales of surgical products such as IOLs
You may also be interested in...
Alcon “Custom” LASIK Approval For Myopia Prohibits Superiority Claims
Alcon hopes that surgeons will accept its LADARVision CustomCornea wavefront-guided laser vision correction system as superior to currently available LASIK systems, despite FDA approval conditions prohibiting claims of superiority
AMO Surgical Devices Outshine Lens Care Products In First Earnings Report
Advanced Medical Optics' sales of intraocular lenses and phacoemulsification devices supported an 8.2% increase in ophthalmic surgical device revenue in the second quarter - the period just prior to AMO's June 29 spin-off from Allergan
Alcon To Keep R&D Focus After Spin-Off From Parent Nestle By April Via IPO
Alcon plans to spend $1.4 bil. on research and development over the next four years as an independent company, following its spin-off from Nestle